Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Gastroenterology
|
June 1, 2015
KIT Signaling Promotes Growth of Colon Xenograft Tumors in Mice and Is Up-Regulated in a Subset of Human Colon Cancers
Evan C Chen, Taylor A Karl, Tomer Kalisky, et al.
Chest
|
July 26, 2020
VTE in ICU Patients With COVID-19
Matthew Moll, Rebecca L Zon, Katelyn W Sylvester, et al.
Blood Advances
|
May 10, 2023
FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years
Shai Shimony, Geoffrey Fell, Evan C Chen, et al.
Nature Genetics
|
September 22, 2025
Rapid epigenomic classification of acute leukemia
Til L Steinicke, Salvatore Benfatto, Maria R Capilla-Guerra, et al.
Blood Advances
|
October 3, 2024
Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort
Jacqueline N Poston, Cassandra Bryan, Annette von Drygalski, et al.
Leukemia & Lymphoma
|
March 15, 2022
Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax
Evan C Chen, Yiwen Liu, Courtney E Harris, et al.
Transplantation and Cellular Therapy
|
April 12, 2021
Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
Evan C Chen, Shuli Li, Ann-Kathrin Eisfeld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2022
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
Evan C Chen, Helen Gandler, Isidora Tošić, et al.
Leukemia
|
February 20, 2024
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML
Shai Shimony, Jan Philipp Bewersdorf, Rory M Shallis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and Decitabine
Evan C Chen, Yiwen Liu, Hayden L Bell, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Gastroenterology
|
June 1, 2015
KIT Signaling Promotes Growth of Colon Xenograft Tumors in Mice and Is Up-Regulated in a Subset of Human Colon Cancers
Evan C Chen, Taylor A Karl, Tomer Kalisky, et al.
Chest
|
July 26, 2020
VTE in ICU Patients With COVID-19
Matthew Moll, Rebecca L Zon, Katelyn W Sylvester, et al.
Blood Advances
|
May 10, 2023
FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years
Shai Shimony, Geoffrey Fell, Evan C Chen, et al.
Nature Genetics
|
September 22, 2025
Rapid epigenomic classification of acute leukemia
Til L Steinicke, Salvatore Benfatto, Maria R Capilla-Guerra, et al.
Blood Advances
|
October 3, 2024
Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort
Jacqueline N Poston, Cassandra Bryan, Annette von Drygalski, et al.
Leukemia & Lymphoma
|
March 15, 2022
Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax
Evan C Chen, Yiwen Liu, Courtney E Harris, et al.
Transplantation and Cellular Therapy
|
April 12, 2021
Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
Evan C Chen, Shuli Li, Ann-Kathrin Eisfeld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2022
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
Evan C Chen, Helen Gandler, Isidora Tošić, et al.
Leukemia
|
February 20, 2024
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML
Shai Shimony, Jan Philipp Bewersdorf, Rory M Shallis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and Decitabine
Evan C Chen, Yiwen Liu, Hayden L Bell, et al.
Page
of 5